Skull base osteomyelitis is a life-threatening condition that sometimes arises as a sequela of otitis media and mastoiditis. We present a retrospective analysis of the clinical course of 3 patients with skull base osteomyelitis that originated in the middle ear or mastoid. All 3 patients were elderly diabetic men who presented with headache. We review the clinical features, radiologic fi ndings, and culture results in all 3 cases, and we describe the treatment regimens that led to a successful response in all 3 patients.
Introduction
Skull base osteomyelitis is a severe osteogenic infection that most oft en occurs in elderly diabetic men. Th is disease process was fi rst reported by Toulmouche in 1838. 1 In 1959, Meltzer and Kelemen described pseudomonal chondritis and osteomyelitis of the external auditory canal and temporal bone. 2 In 1968, Chandler coined the term malignant external otitis to emphasize the high mortality and morbidity associated with this disease. 3 Skull base osteomyelitis that does not begin as external otitis is rare; our review of the literature revealed only a few reports of such cases. For example, Mordant et al in 2006 reported 5 cases of nonotologic osteomyelitis of the middle skull base in Paris. 4 In a more recent report, Bouccara et al described 5 cases of skull base osteomyelitis secondary to sinus or otologic infections. 5 We present a review of 3 cases of skull base osteomyelitis in Singapore that occurred secondary to middle ear or mastoid infections.
Patients and methods
We performed a retrospective review of the clinical course of 3 patients with skull base osteomyelitis who were seen at our institution between 2005 and 2007. All 3 patients were men, and their ages were 66 (patient 1), 69 (patient 2), and 76 (patient 3) years. We compiled and analyzed information on clinical and radiologic fi ndings, culture results, and treatment in each case.
Results and analysis
All 3 patients were diabetic with suboptimal diabetes control. Patient 3 had insulin-dependent diabetes that was complicated by retinopathy, nephropathy, and neuropathy. Patient 1 had a history of right mastoiditis, and patient 3 had a history of left otitis media and mastoiditis (table 1) .
All 3 patients presented with headache. Patients 1 and 3 experienced otologic symptoms; patient 1 had bilateral otalgia and otorrhea, and patient 3 had leftsided otalgia. While patient 2 denied otalgia or otorrhea, he complained of vertiginous giddiness. On physical examination, only patient 2 had an infl amed tympanic membrane with middle ear eff usion (left -sided). None of the patients showed signs of fever or mastoid tenderness. In all 3 patients, the external auditory canals were normal bilaterally with no evidence of granulation tissue or infl ammation. None of the patients developed facial nerve palsy or other cranial neuropathies (table 2) .
Computed tomography (CT) detected erosion of the skull base and clivus, while magnetic resonance imaging (MRI) demonstrated enhancement in the skull base, clivus, and soft tissues that was compatible with skull base osteomyelitis; these changes were seen bilaterally in all 3 patients (fi gures 1 and 2). CT also showed opacifi cation of the middle ear cavity and mastoid air cells, while MRI showed fl uid in the mastoid air cells; these fi ndings were bilateral in patients 1 and 2 and left -sided in Headache is an important distinguishing feature of skull base osteomyelitis, and it was present in all 3 of our patients. Th is symptom is usually absent in uncomplicated cases of otitis media and mastoiditis. Examination showed infl ammation of the tympanic membrane and middle ear fl uid in only 1 patient; there were no signs of otitis media or mastoiditis in the remaining 2 cases. Facial nerve palsy or other cranial neuropathies were absent in all 3 patients.
Radiologic features. Imaging modalities used for the diagnosis of skull base osteomyelitis include CT, MRI, technetium bone scans, gallium scans, and indium-111-labeled leukocyte scans.
CT can defi ne the location and extent of disease at the initial evaluation. However, CT will show bony destruction only when demineralization of 30% or more occurs; once demineralization occurs, CT fi ndings rarely return to normal, and thus it is of little value for monitoring therapeutic eff ect. 8 MRI is helpful in determining the full anatomic extent of soft -tissue disease during the initial evaluation of skull base osteomyelitis. It is available for immediate interpretation, whereas most nuclear medicine scans take several days for results to return. However, MRI does not show any bony involvement, and thus it is ineffective as a single radiologic modality. MRI does serve as a valuable guide to the interpretation of technetium and gallium scans, and thus it is extremely useful in the treatment of skull base osteomyelitis. 9 In patient 2, both CT and MRI showed cervical diskitis at C5-C6 and C6-C7 (table 3) . In patient 3, CT and MRI demonstrated a large enhancing soft -tissue mass in the left fossa of Rosenmüller with bony erosion on the left side of the clivus and skull base involvement. However, biopsies of the postnasal space were negative for malignancy.
Organisms cultured from biopsies of nasopharyngeal soft tissue included alpha-hemolytic streptococci, Staphylococcus aureus, Candida glabrata, and Candida albicans. In the patient with cervical diskitis (patient 2), histopathologic examination of the disk tissue revealed acute on chronic infl ammation with caseation, granulomatous tissue, and microabscesses compatible with tuberculosis. Culture of the disk material in this patient was positive for Aspergillus fl avus. Blood cultures were negative in all 3 patients (table 4) .
With the assistance of infectious disease specialists, we successfully treated our 3 patients with 4 to 6 weeks of intravenous piperacillin/tazobactam (all 3 patients), intravenous ceft azidime (patient 3), and hyperbaric oxygen (patients 1 and 2). In addition, the patient with cervical diskitis secondary to tuberculosis and A fl avus (patient 2) was treated with 9 months of combination isoniazid/pyrazinamide/ethambutol and 6 months of itraconazole (table 4) .
All patients showed considerable clinical improvement aft er therapy. However, patient 3 died of unrelated causes 3 months aft er his diagnosis of skull base osteomyelitis. His death occurred secondary to an infection from his peripherally inserted central catheter. Th is was further complicated by pneumonia, sepsis, acute myocardial infarction, and subarachnoid hemorrhage.
Discussion
Clinical features. Th e diagnosis of skull base osteomyelitis should be considered in any elderly diabetic patient who presents with otitis media or mastoiditis refractory to a standard course of antibiotic therapy. Men are more commonly aff ected than women. 6, 7 All 3 of our patients were diabetic men between the ages of 66 and 76 years. In our 3 cases, CT and MRI complemented each other in helping us determine the anatomic extent of the bony and soft -tissue involvement. CT detected erosion of the skull base and clivus in all 3 patients, and the initial MRI demonstrated enhancement in the skull base and clivus in all 3 patients. Repeat MRI scans revealed improvement in skull base osteomyelitis with antibiotic therapy. Technetium bone scans, gallium scans, and 111 In scans were not performed in any of our cases.
Treatment and outcomes. Patients with skull base osteomyelitis oft en experience multiple medical problems associated with poorly controlled diabetes, and they should be carefully monitored for strict blood glucose control. Treatment has evolved from the initial radical surgical approach described by Chandler 3 in 1968 to the current practice of prescribing long-term, culture-directed antibiotic therapy.
Th ree regimens make up the mainstays of treatment: (1) an aminoglycoside and a beta-lactamase antibiotic, (2) a third-generation cephalosporin such as ceft azidime, and (3) an oral quinolone such as ciprofl oxacin. In cooperation with infectious disease specialists, we successfully treated our 3 patients with 4 to 6 weeks of culture-directed antibiotic therapy. All 3 patients received piperacillin/ tazobactam, and 1 received intravenous ceft azidime. All 3 patients showed considerable clinical improvement within several days, and 4 to 6 weeks of therapy resulted in a cure rate of 100%. Successful intravenous antibiotic treatment was defi ned as a clinical resolution of symptoms and signs coupled with evidence of improvement as demonstrated by MRI. Additionally, as far back as 1989, Shupak osteomyelitis whenever a therapeutic pressure chamber is available. 10 Two of our patients were treated with hyperbaric oxygen in addition to antibiotic therapy. In summary, an absence of otitis externa does not preclude a diagnosis of skull base osteomyelitis, as this condition may originate from any inadequately treated infection near the skull base, including otitis media and mastoiditis. Features suggestive of skull base osteomyelitis include headache in an elderly diabetic man who presents with otitis media or mastoiditis that is refractory to treatment. Investigative radiologic modalities include CT to look for bony destruction and MRI to evaluate soft -tissue involvement. Th e current treatment of choice for skull base osteomyelitis is long-term culture-directed antibiotic therapy, with the response to therapy being gauged by clinical resolution of symptoms and signs and improvement seen on imaging.
